Clinical Trial Update: Safety and Efficacy Study of LB80380 in the Treatment-naive Patients of Chronic Hepatitis B [Phase 2]

View source ↗

Summary

Phase 2 study evaluating safety and efficacy of LB80380 in treatment-naive patients with chronic hepatitis B has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• LB80380

Snippet

Sponsor: LG Life Sciences | Conditions: Chronic Hepatitis B | Phase 2 | Status: COMPLETED